candidiasis-therapeutics-market
Published

December 2016

Global Candidiasis Therapeutics Market – Growth, Trends and Forecasts (2016 – 2021)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global candidiasis therapeutics market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was estimated at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.

Candidiasis is a fungal infection affecting men and women, of all age groups. Approximately 46,000 cases of healthcare-associated invasive candidiasis occur each year in the US. The major drug classes for treatment include azoles, polyenes and echinocandins. The candidiasis therapeutics market is highly fragmented with many Generics. Owing to the widespread nature of the disease, the market is highly dynamic as recurrent infections, limitations of safe and efficacious antifungals and the lack of reliable preventative approaches.

Global Candidiasis Therapeutics - Market Dynamics

The report details several factors driving and restraining the market, some of which are discussed below.

Drivers

  • Increase in the susceptible immune compromised patient pool
  • Growing awareness of candidiasis infection
  • Unmet need for safe products in the market

Restraints

  • Availability of alternative treatments
  • Narrow pipeline molecules
  • Competition from herbal medicines and alternate therapies

Market Segmentation

The global candidiasis therapeutics market has been segmented by route of administration (injection, ointment, oral), drug type (polyene, azole, echinocandin, and others), anatomy type (oral, vulvovaginal, cutaneous, invasive, systemic) and distribution channel (hospitals, clinics, retail pharmacies, drug stores). The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.

Some of the key players in the market are:

  • Basilea Pharmaceuticals
  • Astellas
  • Ferrer Internacional
  • Pacgen Biopharmaceuticals
  • NovaDigm Therapeutics
  • Pevion Biotech
  • Amplyx Pharmaceuticals, Inc.
  • Biomar Microbial Technologies
  • Cidara Therapeutics, Inc.
  • NovaBiotics Limited
  • Others

What the Report Offers

  • Market definition, along with identification of key drivers and restraints for the market.
  • Market analysis with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
  • A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
  • An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
RELATED REPORTS
No related reports available.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?